News

Group Sessions Helpful for Mild Anxiety During COVID-19, Trial Finds

A remote, peer-facilitated group intervention created to provide mental health and social support during the COVID-19 pandemic significantly eased anxiety and depression in adults with systemic scleroderma and mild anxiety, according to data from the SPIN-CHAT trial. Differences between the group of patients who underwent the one-month intervention…

Ofev Safely Slows Lung Function Decline in SSc-ILD Over Long Term

Ofev (nintedanib) safely and effectively slowed lung function decline in people with interstitial lung disease (ILD) associated with systemic sclerosis (SSc-ILD), according to an interim analysis of the ongoing and long-term SENSCIS-ON study. “The SENSCIS-ON trial provides important new evidence about the longer-term use of nintedanib [Ofev] in people living…

‘Stepping Out to Cure Scleroderma’ Events Run Through June

The Scleroderma Foundation invites people to participate in Stepping Out to Cure Scleroderma, a combination of outdoor and virtual fundraising events to support patients and their families, and research into potentially curative treatments during scleroderma‘s awareness month. Local Scleroderma Foundation chapters organized group Stepping Out runs and…

Computer Algorithm Highly Accurate at Detecting PAH in Scleroderma

A computer algorithm called DETECT correctly identified all cases of a potentially life-threatening type of high blood pressure in a group of people with scleroderma in a recent study. The algorithm outperformed standard methods, showing potential as an effective means of screening SSc patients for developing pulmonary arterial hypertension…